Reported 2 days ago
Investor confidence has improved for West Pharmaceutical Services, Inc. (NYSE:WST) as highlighted in Conestoga Capital Advisors' third-quarter 2025 investor letter. The letter noted a 6.18% return for WST in the past month, despite a 5.31% drop over the last year. The company's strong focus on biologics and injectable therapies has led to significant growth, aided by innovation and a strong balance sheet that supports reinvestment and returns to shareholders.
Source: YAHOO